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Objectives: In the present study, a novel pathway by which palmi-
tate potentiates glucose-induced insulin secretion by pancreatic beta
cells was investigated.
Methods: Groups of freshly isolated islets were incubated in 10 mM
glucosewith palmitate, LY294002, wortmannin, and fumonisin B1 for
measurement of insulin secretion by radioimmunoassay (RIA). Also,
phosphorylation and content of AKTand PKCproteinswere evaluated
by immunoblotting.
Results: Glucose plus palmitate and glucose plus LY294002 or
wortmannin (PI3K inhibitors) increased glucose-induced insulin
secretion by isolated pancreatic islets. Glucose at 10 mM induced
AKT and PKCX/L phosphorylation. Palmitate (0.1 mM) abolished
glucose stimulation of AKT and PKCX/L phosphorylation possibly
through PI3K inhibition because both LY294002 (50 KM) and
wortmannin (100 nM) caused the same effect. The inhibitory effect
of palmitate on glucose-induced AKT and PKCX/L phosphorylation
and the stimulatory effect of palmitate on glucose-induced insulin
secretion were not observed in the presence of fumonisin B1, an
inhibitor of ceramide synthesis.
Conclusions: These ﬁndings support the proposition that palmi-
tate increases insulin release in the presence of 10 mM glucose by
inhibiting PI3K activity through a mechanism that involves cer-
amide synthesis.
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G lucose is the major stimulator of insulin secretion bypancreatic beta cell. Glucose enters pancreatic beta cell
through the glucose transporter GLUT2,1 and its metabolism
leads to an increase of the ATP/ADP ratio, which closes the
KATP channels and depolarizes cell membrane. This is
followed by the opening of voltage-sensitive Ca2+ channels
that rises intracellular calcium concentration ([Ca2+]i) and the
exocytosis of insulin-containing granules.2 Other nutrients,
such as free fatty acids (FFA) and amino acids, modulate the
process of glucose-induced insulin release.3,4 Palmitate
acutely does not affect insulin secretion under nonstimulatory
glucose concentrations but markedly increases insulin release
at high glucose concentrations.5,6 This in vitro effect of pal-
mitate is frequently correlated with in vivo observations that
high plasma FFA levels are associated with hyperinsulinemia
and insulin resistance, a key factor involved in the genesis
of type II diabetes mellitus.7,8 Long-chain fatty acids bind to
G-proteinYcoupled receptor, GPR40, which is abundantly
expressed in the pancreas,9,10 and its activation potentiates the
glucose effect on insulin secretion.11 However, a recent study
by Latour et al12 has demonstrated that GPR40 activation
accounts for only 50% of the full acute response to fatty acids
by pancreatic islets. Therefore, additional mechanisms by
which the palmitate increases glucose-induced insulin secre-
tion remains to be fully elucidated.
The activation of pancreatic beta-cell insulin signaling
pathway seems to play a key role in the control of insulin
secretion due to an increase in [Ca2+]i.
13,14 Pancreatic beta
cell from IR (AIRKO) and IGF1R (AIGFIRKO) knockout
mice present low glucose-induced insulin secretion and
insulin-dependent diabetes mellitus, probably due to impaired
Ca2+-activated exocytosis.15 However, other studies have
shown a negative feedback of insulin on its own secretion.
This effect might be a result of PI3K activation16 that leads to
hyperpolarization of pancreatic beta-cell plasma membrane
induced by the opening of the KATP channel.
17 We have re-
cently demonstrated that under basal glucose concentration
(5.6 mM), palmitate acutely up-regulates the insulin signaling
pathway18 and inhibits insulin secretion6 in isolated rat pan-
creatic islets.
Glucose concentration determines the fate of palmitate
metabolism in pancreatic beta cells.6 High concentrations of
glucose induce an increase of A-cell cytosolic malonyl-CoA
content reducing therefore palmitate oxidation19,20 and driving
this fatty acid to ceramide synthesis.21 Considering that pal-
mitate is a substrate for de novo ceramide synthesis,22 and
synthetic ceramide analogs have been described to inhibit the
PI3K/AKT pathway,23,24 the aim of this study was to inves-
tigate the participation of the PI3K pathway in the mecha-
nism by which palmitate increases insulin secretion under
stimulatory glucose concentrations.
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MATERIALS AND METHODS
Reagents
Reagents for protein determination, the apparatus for
sodium dodecyl sulfateYpolyacrylamide gel electrophoresis
(SDS-PAGE) and nitrocellulose ﬁlters (0.45 Km) were from
Bio-Rad (Melville, NY). Trizma, aprotinin, 1-4-dithiothreitol,
phenylmethylsulfonyl ﬂuoride, Triton X-100, glycerol, Tween
20, sodium palmitate, fumonisin B1, wortmannin, collage-
nase type V, and bovine serum albumin (fraction V) were
obtained from Sigma Chemical Co (St Louis, Mo). Immu-
noblot enhanced chemiluminescence detection kit was
purchased from Amersham Biosciences/GE Healthcare
(Buckinghamshire, UK). Antibodies against phospho-
AKT1/2/3 (Ser473), AKT1, AKT2, and PKC were purchased
from Santa Cruz Biotechnology (Santa Cruz, Calif ). Anti-
body against phospho-PKCX/L and LY294002 were acquired
from Cell Signaling Technology, Inc (Beverly, Mass).
Animals
Female albino rats weighing 250 to 350 g were obtained
from the Institute of Biomedical Sciences (University of Sa˜o
Paulo). The animals were kept under standard lighting con-
ditions (12-hour light/dark cycleVlights on at 7:00 AM) at
23 T 1-C, in groups of 5, and were allowed free access to
standard rodent chow and water. The study was approved by
the Ethical Committee of the Institute of Biomedical Sciences,
Sao Paulo University.
FIGURE 1. Insulin secretion from islets acutely incubated
with PI3K inhibitors and palmitate. Groups of 5 freshly
isolated islets were initially incubated for 30 minutes at 37-C
in Krebs-Henseleit buffer containing 5.6 mM glucose. This
solution was replaced, and islets were maintained for
30 minutes in Krebs-Henseleit buffer containing glucose
at 5.6, 10, and 10 mM glucose plus palmitate, LY294002,
and/or wortmannin. At the end of the incubation period,
samples of the supernatants were collected for insulin
measurement by RIA. The results are expressed as mean T SEM
(n = 12, *P G 0.001 vs 5.6 mM glucose, †P G 0.05 vs 10 mM
glucose, ‡P G 0.001 vs 10 mM glucose, and §P G 0.001 vs
10 mM glucose plus palmitate).
FIGURE 2. Effect of PI3K inhibitors on glucose-induced AKT
(Ser473) and PKCX/L phosphorylation. Groups of 200 to 300
freshly islets were preincubated in the absence or presence of
LY294002 or wortmannin. The islets were then incubated for
5 minutes (AKT) or 15 minutes (PKC), in Krebs-Henseleit
buffer containing 5.6, 10, and 10 mM glucose plus LY294002
or 10 mM glucose plus wortmannin. Total protein extracts
(100 Kg) from homogenized islets were resolved in SDS-PAGE,
transferred to nitrocellulose membranes and imunnoblotted
(IB) with pAKT (Ser473), AKT1, and AKT2 antibodies (A) or PKC
and pPKCX/L antibodies (B). Scanning densitometry was
performed on autoradiograms from independent experiments.
The results are expressed as mean T SEM (n = 6, *P G 0.05 vs
5.6 mM glucose and †P G 0.05 vs glucose 10 mM). OD
indicates optical density.
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Isolation of Pancreatic Islets
The islets were isolated by collagenase digestion of the
pancreas according to methodology previously described.25
Hanks buffer containing 137 mM NaCl, 5 mM KCl, 1 mM
CaCl2, 1 mM MgSO4.7H2O, 0.3 mM Na2HPO4, 0.4 mM
KH2PO4, and 4 mM NaHCO3 was used for isolation and
pooling the islets.
Insulin Secretion
Groups of 5 freshly isolated islets were initially incu-
bated for 30 minutes at 37-C in 0.5 mL of KrebsYbicarbonate
buffer (KB) (460 mM NaCl, 96 mM NaHCO3, 20 mM KCl,
4 mM MgCl2, and 4 mM CaCl2) with 0.2% albumin. The
buffer was equilibrated in a mixture of 95%:5% (O2/CO2) and
pH was adjusted to 7.4. This solution was then replaced, and
islets were maintained for additional 30 minutes in KB con-
taining 5.6 mM glucose (G5.6), 10 mM glucose (G10), 10 mM
glucose plus 0.1 mM palmitate (G10P), 10 mM glucose plus
50 KM LY294002, 10 mM glucose plus 100 nM wortmannin,
or 10 mM glucose plus 15 KM fumonisin B1.
Before addition, palmitate was dissolved in ethanol to
form an emulsiﬁed fatty-acid solution. The ﬁnal ethanol
concentration in the incubation medium was always lower
than 0.5%. Preliminary experiments established that this
concentration of ethanol has no effect on basal insulin re-
lease.6 In experiments with LY294002, wortmannin, and
fumonisin B1, the islets were preincubated and postincubated
in the absence or in the presence of the inhibitor as described
in the ﬁgure legends. These inhibitors were dissolved in di-
methyl sulfoxide (DMSO) before addition to the incubation
medium, and the ﬁnal concentration of DMSO was lower
than 0.1%. When required, both ethanol and DMSO were
added in the controls (CTL) to a ﬁnal concentration of 0.5%
and 0.1%, respectively. At the end of the incubation period,
FIGURE 3. Effect of glucose and palmitate on AKT
(Ser473) and PKCX/L phosphorylation. Groups of
200 to 300 freshly isolated islets were preincubated
for 30 minutes at 37-C in Krebs-Henseleit buffer
containing 5.6 mM glucose. This solution was
replaced, and islets were maintained for 5 minutes
(AKT) or 15 minutes (PKC) in Krebs-Henseleit buffer
containing 5.6, 10, and 10 mM glucose plus
palmitate, 10 mM glucose plus palmitate and
wortmannin, or 10 mM glucose plus palmitate
and LY294002. Protein (100 Kg) extracts from
homogenized islets were resolved in SDS-PAGE,
transferred to nitrocellulose membranes and
immunoblotted (IB) with pAKT (Ser473), AKT1, and
AKT2 (A and C) antibodies or pPKCX/L and PKC
antibodies (B). Scanning densitometry was
performed on autoradiograms from independent
experiments. The results are expressed as mean T
SEM (n = 5; *P G 0.05 vs 5.6 mM glucose and
†P G 0.05 vs 10 mM glucose).
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samples of supernatants were collected for insulin measure-
ment by RIA.26
Protein Extraction and Immunoblotting
Groups of 200 to 300 freshly isolated islets were
preincubated for 30 minutes in KB at 37-C containing 5.6 mM
glucose equilibrated with a mixture of 95%:5% (O2/CO2) and
pH 7.4. This solution was then replaced, and islets were
maintained for different periods in KB containing 5.6 mM
glucose (G5.6), 10 mM glucose (G10), 10 mM glucose plus
0.1 mM palmitate (G10P), 10 mM glucose plus 50 KM
LY294002, 10 mM glucose plus 100 nM wortmannin, or
10 mM glucose plus 0.1 mM palmitate and 15 KM fumonisin
B1. Preliminary experiments were performed to establish
the time course changes in the signaling proteins. The chosen
periods to be studied were those in which the most pro-
nounced changes were observed for each protein.
At the end of the incubation, the KB solution was re-
placed by approximately 100 KL of extraction buffer (100 mM
Trizma, 1% SDS, 10 mM sodium pyrophosphate, 100 mM
sodium ﬂuoride, 10 mM ethylenediaminetetraacetic acid, and
10 mM sodium vanadate). The islets were sonicated and boiled
for 10 minutes. The extracts were then centrifuged at
12,000g at 4-C for 20 minutes to remove cellular debris.
Protein determination of the supernatants was performed by
the Bradford dye method using Bio-Rad reagent.
Equal amounts of protein from each sample were added
to Laemmli sample buffer (1:5), boiled for 10 minutes, and
loaded in a SDSYpolyacrylamide gel. The electrotransfer of
the proteins to nitrocellulose membranes was performed for
1 to 2 hours at 120 V using a Bio-Rad miniature transfer
apparatus. Nonspeciﬁc protein binding to nitrocellulose was
reduced by preincubating the membrane for 2 hours with
blocking buffer (5% nonfat dry milk, 10 mM Tris, 150 mM
NaCl, and 0.02% Tween 20) at room temperature. The nitro-
cellulose membranes were incubated for 4 hours at 22-C or
overnight at 4-C with primary antibodies diluted in blocking
buffer containing 3% of nonfat dry milk, and then washed
for 30 minutes in blocking buffer without milk. The blots
were subsequently incubated with peroxidase-conjugated sec-
ondary antibody for 1 hour and processed for chemilumines-
cent detection of immunoreactive bands. When necessary,
the membranes were stripped, washed, and reprobed with
different primary antibodies. Band intensities were quantiﬁed
by optical densitometry (Scion Image-Release Beta 3b, NIH,
Bethesda, MD) of the developed autoradiograph.
FIGURE 4. Effect of ceramide synthesis blockade
on AKT (Ser473) and PKCX/L phosphorylation
and insulin secretion. Groups of 200 to 300
freshly isolated islets were initially incubated for
30 minutes at 37-C in Krebs-Henseleit 5.6 mM
glucose in the absence or presence of fumonisin
B1. This solution was replaced, and islets were
maintained for 5 minutes under Krebs-Henseleit
containing 5.6, 10, and 10 mM glucose plus
palmitate or 10 mM glucose plus palmitate and
fumonisin B1. Total protein extracts (100 Kg)
from homogenized islets were resolved in
SDS-PAGE, transferred to nitrocellulose
membranes and imunnoblotted (IB) with pAKT
(Ser473), AKT1, and AKT2 antibodies (n = 4) (A)
or PKC and pPKCX/L antibodies (n = 4) (B).
Scanning densitometry was performed on
autoradiograms from independent experiments.
Groups of 5 islets were preincubated as
described in Figure 1 and after that incubated
with 10 mM glucose, 10 mM glucose plus
palmitate, or 10 mM glucose plus palmitate and
fumonisin B1. At the end of the incubation
period, samples of the supernatants were
collected for insulin measurement by RIA
(n = 15) (C). The results are expressed as
mean T SEM (*P G 0.05 vs 5.6 mM glucose,
†P G 0.05 vs 10 mM glucose, and ‡P G 0.05 vs
10 mM glucose plus palmitate).
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Statistical Analysis
Results are presented as mean T SEM. Signiﬁcant dif-
ferences between groups were analyzed by using analysis
of variance followed by the Tukey posttest. The level of sig-
niﬁcance was set at P G 0.05.
RESULTS
Pharmacological PI3K Inhibition and Palmitate
Increase Insulin Secretion in the Presence of
Stimulatory Glucose Concentration
As expected, isolated rat islets incubated for 30 minutes
in the presence of 10 mM glucose (G10) displayed a 2.0-fold
increase in insulin secretion when compared with G5.6. The
addition of palmitate in the presence of 10 mM glucose
provoked an additional 1.5-fold increase in insulin secretion.
Similarly, the addition of the PI3K inhibitors (LY294002 and
wortmannin) to the medium containing 10 mM glucose also
provoked ~1.5-fold increase in insulin secretion. The incuba-
tion with palmitate and LY294002 in the presence of 10 mM
glucose resulted in an additional increase of insulin secretion,
approximately 1.5-fold higher than that observed when the
drug was added alone. This additional effect was not observed
with wortmannin under similar condition (Fig. 1).
Glucose-Induced Phosphorylation of AKT
(Ser473) and PKCX/L is Blocked by
Pharmacological Inhibition of PI3K and Addition
of Palmitate
Glucose at 10 mM induced a 1.7-fold increase in AKT
(Ser473) phosphorylation (Fig. 2A). This signiﬁcant increase
of AKT phosphorylation was blocked by the addition of 2
PI3K inhibitors; wortmannin and LY294002. In addition to
AKT phosphorylation, 10 mM glucose induced a 1.5-fold
increase in PKCX/L phosphorylation, which was also blocked
by the addition of wortmannin and LY294002 (Fig. 2B).
Similarly to wortmannin and LY294002, palmitate acutely
inhibited glucose-induced AKT (Ser473) and PKCX/L phos-
phorylation (Figs. 3A, B). Incubation of pancreatic islets with
10 mM glucose and palmitate in the presence of LY294002 or
wortmannin induced a further decrease of AKT (Ser473)
phosphorylation (Fig. 3C).
Blockade of Ceramide Synthesis Prevents
Palmitate-Stimulated Insulin Secretion and
Inhibition of AKT and PKCX/L Phosphorylation
and Insulin Secretion
Fumonisin B1 was used to investigate whether the ef-
fects of palmitate described herein were somehow secondary
to ceramide generation. Fumonisin B1 treatment abolished the
effect of palmitate on AKT (Ser473) and PKCX/L phosphor-
ylation (Figs. 4A, B). The ceramide synthesis also abolished
palmitate potentiation of insulin secretion in the presence of
10 mM glucose (Fig. 4C).
DISCUSSION
The modulation of glucose-induced insulin secretion by
palmitate has been investigated by several groups.27,28 Acute
exposure of the pancreatic beta cells to both high glucose
concentration and saturated FFA results in a substantial in-
crease of insulin release, whereas a chronic exposure leads
to desensitization and suppression of the secretory re-
sponse.29 The precise molecular mechanism involved in the
interplay between glucose and fatty-acid metabolism and thus
insulin secretion is, however, far from being completely
understood. Apparently, GPR40 participates in the chronic
effect of palmitate in reducing glucose-induced insulin se-
cretion and is partially responsible for the acute FFA over the
effect on insulin release in the presence of high glucose
concentration.12,30
Glucose concentration plays a determinant role in the
control of palmitate metabolism in pancreatic beta cell. To
exert a stimulatory effect on insulin release, FFA need to
enter the cell and conjugate with coenzyme A (CoA), form-
ing long-chain acyl-CoAs (LC-CoA) that serve as impor-
tant effector molecules, controlling a large number of
signaling pathways, including PKCs and other exocytotic
machinery proteins.31,32 Under high glucose concentration,
there is also an increased [U-14C]-palmitate incorporation
into several phospholipids, such as phosphatidylcholine
and phosphatidylserine, which are able to stimulate insulin
secretion.6
There is consistent evidence that insulin pathway regu-
lates its own secretion in a glucose-dependent manner.33,34
Pancreatic beta cells express insulin receptor (IR),35 insulin
receptor substrates (IRS1/2),36 and downstream proteins that
participate in the insulin signaling pathway, such as PI3K and
AKT/PKB.37,38 Several studies have shown that PI3K par-
ticipates in pancreatic insulin secretion. PI3K activation by
insulin induces plasma membrane hyperpolarization that leads
to a decrease in insulin secretion.17 On the other hand, in-
hibition of PI3K sustains the closure of the KATP channel
induced by glucose leading to a further increase of insulin
secretion at high glucose concentration.16,39 As conﬁrmed
herein, PI3K inhibition increased glucose-induced insulin
secretion. LY294002 also directly inhibits the voltage-
dependent K+ current.40,41 This additional effect may explain
the more pronounced increase of insulin secretion induced
by glucose in the presence of LY294002 as compared with
wortmannin under similar conditions.
Glucose metabolism leads to an increase of ATP/ADP
ratio and closure of ATP-sensitive K+ channels causing mem-
brane depolarization followed by VDCC opening and ex-
trusion of insulin granules. Concomitantly, glucose also
activates PI3K as demonstrated by others.17 As PKCX/L acti-
vation occurs directly as a consequence of PI3K stimula-
tion42,43 or indirectly via PDK-1,44 the activation of PI3K by
glucose is corroborated by the blockade of the glucose-
induced augment in AKT and PKCX/L phosphorylation
with the addition of LY294002 and wortmannin to the incu-
bation medium.
As PI3K activation is thought to be responsible for a
decrease in insulin secretion, the present data demonstrat-
ing that stimulatory concentrations of glucose induce both
AKT and PKCX/L phosphorylation seem apparently contra-
dictory. However, our interpretation for these observations is
that PI3K activation does not fully suppress insulin secretion
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at high glucose concentrations and may serve as a constant
negative feedback mechanism to prevent excessive insulin
release and thus hyperinsulinemia.17
The involvement of PI3K in the potentiation of glucose-
induced insulin secretion by palmitate was therefore investi-
gated in the present study as a putative candidate to control
pancreatic islet function. To ascertain the participation of
PI3K pathway, the effect of palmitate on AKT and PKCX/L
phosphorylation was evaluated. Palmitate mimicked the ef-
fect of LY294002 and wortmannin on the phosphorylation of
these proteins, suggesting that palmitate might directly or in-
directly regulates PI3K activity.
Palmitate has been shown to inhibit the PI3K/AKT
pathway in insulin-responsive cells.45,46 For instance, fatty-
acid infusion (5 hours) impairs insulin-stimulated phosphor-
ylation of AKT in skeletal muscle.47 These effects of FFA
might be a result of ceramide synthesis, a second messenger
generated mainly via the de novo pathway, or activation of
sphingomyelinases, which then release ceramide from sphin-
gomyelin.22 The sphingolipid ceramide is classically reported
as a molecule that controls antiproliferative responses such
as apoptosis, growth arrest, differentiation, and senescence.48
The decrease in AKT phosphorylation induced by pal-
mitate is dependent on ceramide synthesis in skeletal
muscle.49,50 Stratford and collaborators demonstrated that
the sphingolipid ceramide negatively regulates AKT phos-
phorylation by 2 independent mechanisms. First, ceramide
speciﬁcally blocks the translocation of AKT to the plasma
membrane through a directly binding to the pleckstrin
homology domain. Second, ceramide induces the depho-
sphorylation of AKT by a mechanism dependent on protein
phosphatase 2A.51 However, ceramide-induced modulation of
insulin signaling pathway also occurs upstream of AKT
because pretreatment with C(6)-ceramide reduced insulin-
induced PI3K activity in rat adipocytes.52
Although it has been previously suggested that inhibi-
tion of insulin secretion after chronic exposure to palmitate
and oleate is probably not related to de novo ceramide syn-
thesis,53 this sphingolipid certainly plays an important role in
pancreatic beta-cell function. Prolonged exposure to elevated
levels of palmitate affects glucose-stimulated insulin gene
expression, long-term insulin secretion, and cellular repli-
cation by mechanisms that involve ceramide synthesis.21,54
Using a pharmacological inhibitor of ceramide synth-
esis, fumonisin 1B, we demonstrated that the acute effect of
palmitate in increasing insulin secretion and decreasing AKT
and PKCX/L phosphorylation is probably related to ceramide
synthesis by hydrolysis of sphingomyelin. This is the ﬁrst
study that correlates ceramide synthesis to an acute effect of
palmitate in the presence of stimulatory concentrations of
glucose. Similarly to our study, acute exposure to palmitate
(1Y2 hours) in the presence of high concentrations of glucose
has been shown to decrease AKT activity due to an increase in
ceramide synthesis in cardiac muscle.46
These results combined indicate that the modulation of
PI3K pathway by palmitate occurs, at least in part, through
ceramide generation. This mechanism might culminate in the
down-regulation of PI3K activity (as demonstrated by AKT
and PKCX/L phosphorylation) and an increase of insulin
secretion in the presence of stimulatory concentrations of
glucose. Thus, the present study describes an additional
mechanism by which FFA affect pancreatic islet physiology.
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